Last reviewed · How we verify
Tamsulosin and solifenacin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Tamsulosin and solifenacin (Tamsulosin and solifenacin) — Jeil Pharmaceutical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tamsulosin and solifenacin TARGET | Tamsulosin and solifenacin | Jeil Pharmaceutical Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tamsulosin and solifenacin CI watch — RSS
- Tamsulosin and solifenacin CI watch — Atom
- Tamsulosin and solifenacin CI watch — JSON
- Tamsulosin and solifenacin alone — RSS
Cite this brief
Drug Landscape (2026). Tamsulosin and solifenacin — Competitive Intelligence Brief. https://druglandscape.com/ci/tamsulosin-and-solifenacin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab